Xenon Pharmaceuticals Inc (XENE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2020 | 12-2019 | 12-2018 | 12-2017 | 12-2016 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 45,009 | 24,755 | 67,754 | 20,486 | 17,095 |
| Marketable Securities | 131,988 | 116,603 | 51,552 | 23,181 | 47,051 |
| Receivables | 1,822 | 813 | 151 | 438 | 200 |
| TOTAL | $181,783 | $144,866 | $121,332 | $44,821 | $65,675 |
| Non-Current Assets | |||||
| PPE Net | 3,554 | 1,660 | 991 | 1,070 | 1,404 |
| Other Non-Current Assets | 3,849 | 1,171 | 105 | 230 | 408 |
| TOTAL | $7,403 | $2,831 | $1,096 | $1,300 | $1,812 |
| Total Assets | $189,186 | $147,697 | $122,428 | $46,121 | $67,487 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 4,650 | N/A | 700 | N/A |
| Accounts payable and accrued liabilities | 10,874 | 8,818 | 4,119 | 3,383 | 3,586 |
| TOTAL | $14,781 | $43,379 | $4,119 | $4,083 | $3,586 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | 10,889 | 15,014 | 6,104 | N/A |
| Deferred Revenues | 3,642 | 29,743 | N/A | N/A | N/A |
| Other Non-Current Liabilities | 3,050 | 743 | 0 | 0 | 0 |
| TOTAL | $3,050 | $12,341 | $15,014 | $6,104 | $N/A |
| Total Liabilities | $17,831 | $55,720 | $19,133 | $10,187 | $3,586 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 35,809 | 34,956 | N/A | N/A | 17,936 |
| Common Shares | 397,748 | 294,244 | 265,923 | 173,841 | 173,246 |
| Retained earnings | -278,492 | -249,655 | -207,885 | -173,388 | -142,681 |
| Other shareholders' equity | -990 | 6,742 | -990 | -990 | -990 |
| TOTAL | $171,355 | $91,977 | $103,295 | $35,934 | $63,901 |
| Total Liabilities And Equity | $189,186 | $147,697 | $122,428 | $46,121 | $67,487 |